Post by AbbVie on X
AbbVie@abbvie
XNEWS: The @EU_Commission has granted marketing authorization of our medicine as part of a combination regimen for adults with relapsed/refractory (R/R) follicular #lymphoma (FL), developed with @Genmab. Read more: t.co
10 likes2 repliesPosted Jul 6, 2026